ACN vs EPAM: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: EPAM is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACN and EPAM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACN and EPAM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Accenture is a global professional services company that helps businesses, governments, and other organizations across more than 120 countries build digital infrastructure, optimize operations, and accelerate growth. The company operates across five major service areas: Strategy and Consulting, Technology Services, Operations, Industry X (engineering and manufacturing digitization), and Song (marketing and customer experience). It earns revenue through a mix of consulting engagements, managed services contracts, and increasingly fixed-price, outcome-based arrangements, with managed services growing faster at roughly 10% year over year as of Q2 FY2026. The company serves clients in virtually every major industry vertical, from financial services and health to communications and government, and generates the majority of its revenue outside North America.

Full ACN guide

EPAM Systems is a global provider of digital-engineering and IT services, meaning it designs and builds custom software and platforms for large enterprises rather than selling its own products. It reported 2025 revenue of about $5.46 billion, up roughly 15% year over year, with Financial Services its single largest industry vertical and the Americas its largest geography. The business runs on billable engineers: revenue comes from staffing skilled software teams against client projects, so utilization, attrition, and wage costs drive margins far more than any single contract. EPAM has long been known for a deep, technically-strong engineering culture that lets it charge premium rates versus larger, scale-oriented rivals.

Full EPAM guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ACN drivers: Enterprise AI implementation at scale; Shift to recurring, outcome-based revenue.
• EPAM drivers: AI-native services scale-up; Enterprise demand recovery and utilization.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most structural bear-case concern is AI cannibalization: if generative AI and agentic AI tools automate the coding, testing, documentation, and process management that make up a significant portion of Accenture's billable work, clients may require fewer hours per engagement, compressing revenue without a commensurate reduction in costs. For EPAM, the central risk is demand cyclicality: enterprise technology budgets tighten in downturns, and as a project-based services firm EPAM feels that quickly through lower utilization and slower bookings, which is part of why 2026 guidance is cautious.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACN if you believe its drivers more; EPAM if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACN and EPAM guides.

ACN. Accenture's trailing P/E of roughly 10 to 13x represents a sharp discount to its own 5-year average of approximately 25x, a compression driven by AI cannibalization fears, federal spending headwinds, and a broader de-rating of large-cap professional services stocks rather than by any deterioration in underlying earnings, which have continued to grow. Operating margins near 17% and projected free cash flow of $10.8 billion to $11.5 billion in FY2026 reflect a business that is fundamentally sound and continuing to expand profitability. The elevated dividend yield above 3.5% (elevated because the share price has fallen roughly 38 to 40% over the prior 12 months) is now higher than Accenture's long-run average and is well covered by both earnings (roughly 52% payout ratio) and cash flows.

EPAM. Figures are approximate and tied to the asOf date; verify live numbers before acting. EPAM has historically commanded a premium valuation for its engineering quality and fast growth, but with growth cooling to single digits the market is repricing it more like a mature services firm. The key question is whether AI-native services reaccelerate growth and lift margins, or whether generative AI erodes billable demand faster than EPAM can capture new work.

Headline figures (approximate, 2026-06-27): ACN shows revenue (ttm) ~$72 billion, revenue (fy2025, ended aug 31 2025) ~$69.7 billion (+7% YoY), q3 fy2026 revenue ~$18.7 billion (+5.6% YoY), q3 fy2026 eps (diluted) ~$3.82 (vs $3.52 in Q3 FY2025); EPAM shows revenue (ttm) ~$5.5 billion (2025 was ~$5.46 billion, up ~15% year over year); verify live, 2026 revenue guidance ~$5.70 billion to $5.87 billion (implies high-single-digit growth), profitability Non-GAAP operating margin guided to 15% to 16%; non-GAAP diluted EPS guided ~$12.60 to $12.90, balance sheet Historically low debt with meaningful cash; targets cumulative free cash flow above $1.8 billion for 2026 to 2028; verify current figures.

ACN and EPAM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACN and EPAM exposure against your real portfolio. It is not an investment adviser.